WORLD OF MICROBIOLOGY AND IMMUNOLOGY Tuberculosis
555
•
segment of DNA to be moved is physically cut from its origi-
nal location and then inserted into a new location. The DNA
from which the tranposon is removed is termed the donor
DNA, and the DNA to which the transposon is added is termed
the receptor DNA.
Transposons are not passive participants in transposi-
tion. Transposons carry the genes that code for the enzymes
needed for transposition. In essence, they carry the mecha-
nisms of transposition with them as they move or jump (hence
Barbara McClintok’s original designation of “jumping genes”)
throughout or across genomes. Transposons carry special
insertion sequences(IS elements) that carry the genetic infor-
mation to code for the enzyme transposase that is required to
accomplish transposition mutations. One of the most impor-
tant mechanisms of transposase is that they are the enzymes
responsible for cutting the receptor DNA to allow the insertion
of the transposon.
Transitions are a radical mutational mechanism. The
physical removal of both DNA and genes can severely damage
or impair the function of genes located in the transposons
(especially those near either terminus). Correspondingly, the
donor molecules suffer a deletion of material that may also
render the remaining genes inoperative or highly impaired
with regard to function.
McClintok’s discovery of transposons, also termed
“jumping genes” in the late 1940’s (before the formation of the
Waston-Crick model of DNA) resulted in her subsequent
award of a Nobel Prize for Medicine or Physiology.
Transposition segments termed retrotransposons may
also utilize an RNA intermediate complimentary copy to
accomplish their transposition.
Transposition can radically and seriously affect pheno-
typic characteristics including transfer of antibiotic resistance
in bacterium. Following insertion, transposed genetic ele-
ments usually generate multiple copies of the genes trans-
ferred, further increasing their disruption to both the genotype
and phenotypic expression.
See alsoAntibiotics; Microbial genetics
TREPONEMA•seeSYPHILIS
TRYPANOSOME•seeCHAGAS’DISEASE
TTuberculosisUBERCULOSIS
Tuberculosis (TB) is an infectious disease of the lungs caused
by the bacterium Mycobacterium tuberculosis.In the mid-
nineteenth century, about one-fourth of the mortality rate was
attributable to tuberculosis. It was particularly rampant in
early childhood and young adulthood. Its presence was felt
throughout the world, but by the 1940s, with the introduction
of antibiotics, there was a sharp decline of cases in developed
countries. For less-developed countries with poor public
healthstructures, tuberculosis is still a major problem. Since
1989, however, there has been an increase in reported cases in
economically advanced countries due mainly to immunosup-
pression associated with AIDS, and the emergence of antibi-
otic-resistant strains of TB.
The bacillus infects the lungs of those who inhale the
infected droplets formed during coughing by an individual
who has an active case of the disease. It can also be transmit-
ted by unpasteurized milk, as animals can be infected with the
bacteria. The disease is dormant in different parts of the body
until it becomes active and attacks the lungs, leading to a
chronic infection. Symptoms include fatigue, loss of weight,
night fevers and chills, and persistent coughing with sputum-
streaked blood. The virulent form of the infection can then
spread to other parts of the body. Without treatment, the con-
dition is eventually fatal.
Chest x rays and sputum examinations can show the
presence of tuberculosis. Tuberculin, a purified protein taken
from the tuberculosis bacilli, is placed under the skin of the
forearm during a tuberculosis skin test. In two or three days if
there is a red swelling at the site, the test is positive, and indi-
cates TB infection, but not necessarily active TB disease.
Early detection of the disease facilitates effective treatment to
avoid the possibility of it becoming active later on.
Populations at risk of contracting TB are people with
certain medical conditions or those using drugs for medical
conditions that weaken the immune system. Others at risk are
low-income groups, people from undeveloped countries with
high TB rates, people who work in or are residents of long-
term care facilities (nursing homes, prisons, hospitals), those
who are significantly underweight, alcoholics, and intra-
venous drug users.
Traces of lesions from tuberculosis have been found in
the lungs of ancient Egyptian mummies. The recent discovery
of a Pre-Columbian mummy has resolved the debate on
whether or not European explorers introduced the disease to
the New World. Lung samples from a Peruvian woman who
lived 500 years before Columbus discovered America show a
lump that was identified as tuberculosis by DNAtesting.
Hippocrates, a Greek physician who lived from 460 to 370
B.C., described the disease. The Greek name for the disease
was phthisis,derived from the verb phthinein,meaning to
waste away. Tuberculosis was also called consumption
because of the wasting away effects (notably, significant
losses of weight over a period of time) of the disease.
In 1839, Johann Schonlein is credited with first labeling
the disease tuberculosis. In 1882, the tubercle bacillus was
discovered by Robert Koch, the German physician who pio-
neered the science of bacteriology. This landmark discovery
was followed eight years later by his extraction of a protein
from dead bacilli called tuberculin. This protein is still used to
test for the presence of TB infection in a dormant or early
stage. Another important diagnostic breakthrough came in
1895 with the discovery of Wilhelm Conrad Roentgen’s x
rays. The presence of TB lesions was detected on x rays.
Two twentieth century French scientists, Albert
Calmette and Camille Guerin, developed a vaccineagainst
tuberculosis from a weakened strain of bovine bacillus. Called
BCG for Bacillus-Calmette-Guerin, this vaccine is the only
womi_T 5/7/03 11:02 AM Page 555